Difference between revisions of "2013-11-21 TSC UDI Task Force"

From HL7 TSC
Jump to navigation Jump to search
(Created page with '{{subst::2013-11-14 TSC UDI Task Force}}')
 
 
(2 intermediate revisions by the same user not shown)
Line 9: Line 9:
 
| width="0%" colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 TSC Meeting Minutes''' <br/>
 
| width="0%" colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 TSC Meeting Minutes''' <br/>
 
'''Location: https://global.gotomeeting.com/join/134453157  
 
'''Location: https://global.gotomeeting.com/join/134453157  
| width="0%" colspan="1" align="left" style="background:#f0f0f0;"|'''Date: 2013-11-14'''<br/> '''Time: 4:00 PM U.S. Eastern DAYLIGHT'''
+
| width="0%" colspan="1" align="left" style="background:#f0f0f0;"|'''Date: 2013-11-21'''<br/> '''Time: 4:00 PM U.S. Eastern '''
 
|-
 
|-
 
| width="0%" colspan="2" align="right"|'''Facilitator''': Paul Knapp
 
| width="0%" colspan="2" align="right"|'''Facilitator''': Paul Knapp
Line 20: Line 20:
 
|colspan="2"|Attendee ||role
 
|colspan="2"|Attendee ||role
 
|-  
 
|-  
|x||Paul Ashford||ICCBBA
 
|-
 
 
|x ||Nagesh Bashyam||Drajer
 
|x ||Nagesh Bashyam||Drajer
 
|-  
 
|-  
|x||Hans Buitendijk||Siemens
+
| x||Hans Buitendijk||Siemens
 
|-
 
|-
 
|x ||Todd Cooper  ||DEV cochair
 
|x ||Todd Cooper  ||DEV cochair
 
|-
 
|-
| ||Pat Distler|| HIBC
+
|x||Erin Fields|| FDA
|-
 
|x||Pat Fields|| FDA
 
|-
 
|x|| Julian Goldman
 
|-
 
| x||Matt Graham ||Mayo, Mobile Health cochair
 
|-
 
| ||Grahame Grieve ||FHIR FMG, MnM
 
 
|-
 
|-
|x ||Christian Hay ||GS1
+
|regrets 11/21 ||Christian Hay ||GS1
 
|-
 
|-
 
|x || Wendy Huang||CGIT
 
|x || Wendy Huang||CGIT
|-
 
|x|| Anne Kling ||Mitre
 
 
|-
 
|-
 
|x ||Paul Knapp ||FTSD co-chair, UDI Task Force Chair, ITS and FM cochairs, FMG
 
|x ||Paul Knapp ||FTSD co-chair, UDI Task Force Chair, ITS and FM cochairs, FMG
Line 49: Line 37:
 
|-  
 
|-  
 
|x||Brett Marquard||SDWG
 
|x||Brett Marquard||SDWG
 
 
|-
 
|-
|x||Ken McCaslin||Quest
+
|x ||John Moehrke|| GE
 
|-
 
|-
|x ||Behnaz Minaei ||FDA
+
| x ||JDL Nolen ||
|-
 
|x ||Matt Rahn || ONC
 
 
|-
 
|-
 
|x||Brian Pech||KP
 
|x||Brian Pech||KP
Line 63: Line 48:
 
|x ||John Rhoads ||cochair DEV
 
|x ||John Rhoads ||cochair DEV
 
|-
 
|-
| x||Paul Schluter ||with DEV and liaise with Continua and IHE PCP
+
|x ||Scott Robertson||Pharmacy co-chair
 
|-
 
|-
| ||Pat Van Dyke ||EHR cochair, ADentalA liaison
+
|x||Tania Snioch||GS1 Australia
 
|-
 
|-
| || Pele Yu ||Child Health
+
| x||Pat Van Dyke ||EHR cochair, ADentalA liaison
|-
 
 
|-
 
|-
 
|colspan="3" style="background:#f0f0f0;"|
 
|colspan="3" style="background:#f0f0f0;"|
Line 79: Line 63:
 
#:Objectives: to define a conceptual model for UDI to ensure interoperable implementation across the suite of HL7 standards (v2, v3 message4, v3 CDA, FHIR
 
#:Objectives: to define a conceptual model for UDI to ensure interoperable implementation across the suite of HL7 standards (v2, v3 message4, v3 CDA, FHIR
 
#:Goals for today:
 
#:Goals for today:
#*Review last week's discussion at [[2013-11-07 TSC UDI Task Force]]
+
#*Review last week's discussion at [[2013-11-14 TSC UDI Task Force]]
#* Review FDA-UDI storage proposal and coding
+
#* Review the [http://gforge.hl7.org/gf/download/docmanfileversion/7685/11177/%46%44%41%2d%55%44%49%20%49%64%65%6e%74%69%66%69%65%72%73%20%32%30%31%33%31%31%31%34%2e%78%6c%73%78 updated spreadsheet]
#Review Paul's draft model
 
 
#Next steps
 
#Next steps
 
# Adjourn
 
# Adjourn
Notes:
 
 
UDI rule out for guidance/comment until about Nov 24 2013
 
  
  
  
 
===Minutes===
 
===Minutes===
'''Minutes/Conclusions Reached:'''<br/>
+
'''Minutes/Conclusions Reached:'''<br/> convened at 4:08 PM
Convened at 4:05 PM
+
#Roll Call
 +
#* Paul reviews the [http://gforge.hl7.org/gf/download/docmanfileversion/7685/11177/%46%44%41%2d%55%44%49%20%49%64%65%6e%74%69%66%69%65%72%73%20%32%30%31%33%31%31%31%34%2e%78%6c%73%78 design spreadsheet]
 +
#**document with the harmonized pattern also reviewed
 +
#**supplemental serial number as second serial number or business case for serial + lot number - cannot confirm with no representatives on today's call.
 +
#**Nagesh asks about cardinality of udi vs di. DI is the mandatory part of the udi and the FDA would like to see users validate the DI.
 +
#**Austin notes that the pattern is referring to V3 datatypes but needs to be conceptual across paradigms.
 +
#Next steps
 +
#*Paul will send the updated pattern document around for suggestions.  Paradigm specific areas can create addenda to specify representation in V2, V3, etc.
 +
#*Bring the addenda together with the pattern and have a call in a few weeks on Dec 12th
 +
#*Once the document is signed off it can go to an out of cycle harmonization.
 +
# Adjourn 5:02 PM
  
Paul reviews FDA-UDI Identifiers 20131108 PD.xlsx
 
 
Terrie has the FDA OID to send Paul, confirmed by Brett as 2.16.840.1.113883.3.3719
 
 
   
 
   
The exchange format (string) is always the human readable format with parentheses
 
 
Christian notes a pilot with Mercy Health have worked with this successfully and would like to have them explain their approach. Terrie notes they have seen these documents and they are exchanging with the Am College of Cardiology, but they are a GS1 shop.  Christian adds they pull the information and parse the GS1 UDI and use it internally but plan to exchange externally in future.  Terrie notes that FDA funded the pilot but they have not specifically been asked this question yet; she will ask them.
 
 
Austin notes that pattern harmonization would be a good place to resolve and document the pattern. Paul notes that it would be an HL7 solution so the others would not necessarily be present.
 
 
Will next create a model to capture the decomposed elements of the UDI for next week's review.  At that time we can also review how it might be used in each of the different HL7 standards.
 
 
[http://gforge.hl7.org/gf/download/docmanfileversion/7685/11177/%46%44%41%2d%55%44%49%20%49%64%65%6e%74%69%66%69%65%72%73%20%32%30%31%33%31%31%31%34%2e%78%6c%73%78 Documents] will be available as linked from the TSC wiki.
 
 
Julian adds it's been difficult to find a good example and datatypes mapping for transferring UDI.  Austin notes that this work is a precursor to make that happen. Intact human readable string is what is transferred, no matter where HL7 will put it.
 
 
Adjourned 5:05 PM
 
  
 
===Next Steps===
 
===Next Steps===
Line 116: Line 90:
 
|-
 
|-
 
|colspan="4" |'''Actions''' ''(Include Owner, Action Item, and due date)''<br/>
 
|colspan="4" |'''Actions''' ''(Include Owner, Action Item, and due date)''<br/>
*distribute the [http://gforge.hl7.org/gf/download/docmanfileversion/7685/11177/%46%44%41%2d%55%44%49%20%49%64%65%6e%74%69%66%69%65%72%73%20%32%30%31%33%31%31%31%34%2e%78%6c%73%78 updated spreadsheet] .
+
*.
 
|-
 
|-
 
|colspan="4" |'''Next Meeting/Preliminary Agenda Items'''<br/>
 
|colspan="4" |'''Next Meeting/Preliminary Agenda Items'''<br/>
*[[2013-11-21 TSC UDI Task Force]].
+
*[[2013-12-12 TSC UDI Task Force]].
 
|}
 
|}
  
  
 
© 2013 Health Level Seven® International.  All rights reserved.
 
© 2013 Health Level Seven® International.  All rights reserved.

Latest revision as of 22:06, 21 November 2013

TSC UDI TF

Meeting Info/Attendees

HL7 TSC Meeting Minutes

Location: https://global.gotomeeting.com/join/134453157

Date: 2013-11-21
Time: 4:00 PM U.S. Eastern
Facilitator: Paul Knapp Note taker(s): Lynn Laakso
Quorum not defined
Attendee role
x Nagesh Bashyam Drajer
x Hans Buitendijk Siemens
x Todd Cooper DEV cochair
x Erin Fields FDA
regrets 11/21 Christian Hay GS1
x Wendy Huang CGIT
x Paul Knapp FTSD co-chair, UDI Task Force Chair, ITS and FM cochairs, FMG
x Austin Kreisler TSC
x Brett Marquard SDWG
x John Moehrke GE
x JDL Nolen
x Brian Pech KP
x Terrie Reed FDA informatics and ONC with UDI incorporation into certification activities
x John Rhoads cochair DEV
x Scott Robertson Pharmacy co-chair
x Tania Snioch GS1 Australia
x Pat Van Dyke EHR cochair, ADentalA liaison

Agenda

  1. Roll Call
  2. Review draft agenda
  3. Task Force
    Definition: a purpose tasked committee with a lifetime to match the issue
    Objectives: to define a conceptual model for UDI to ensure interoperable implementation across the suite of HL7 standards (v2, v3 message4, v3 CDA, FHIR
    Goals for today:
  4. Next steps
  5. Adjourn


Minutes

Minutes/Conclusions Reached:
convened at 4:08 PM

  1. Roll Call
    • Paul reviews the design spreadsheet
      • document with the harmonized pattern also reviewed
      • supplemental serial number as second serial number or business case for serial + lot number - cannot confirm with no representatives on today's call.
      • Nagesh asks about cardinality of udi vs di. DI is the mandatory part of the udi and the FDA would like to see users validate the DI.
      • Austin notes that the pattern is referring to V3 datatypes but needs to be conceptual across paradigms.
  2. Next steps
    • Paul will send the updated pattern document around for suggestions. Paradigm specific areas can create addenda to specify representation in V2, V3, etc.
    • Bring the addenda together with the pattern and have a call in a few weeks on Dec 12th
    • Once the document is signed off it can go to an out of cycle harmonization.
  3. Adjourn 5:02 PM


Next Steps

Actions (Include Owner, Action Item, and due date)
  • .
Next Meeting/Preliminary Agenda Items


© 2013 Health Level Seven® International. All rights reserved.